Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 2
1990 1
1991 1
1992 2
1993 2
1994 9
1995 19
1996 19
1997 20
1998 21
1999 25
2000 22
2001 40
2002 37
2003 30
2004 53
2005 45
2006 40
2007 31
2008 41
2009 52
2010 51
2011 60
2012 70
2013 81
2014 80
2015 77
2016 58
2017 56
2018 53
2019 47
2020 45
2021 36
2022 40
2023 29
2024 14

Text availability

Article attribute

Article type

Publication date

Search Results

1,184 results

Results by year

Filters applied: . Clear all
Page 1
Endothelial Cells in the Tumor Microenvironment.
Sobierajska K, Ciszewski WM, Sacewicz-Hofman I, Niewiarowska J. Sobierajska K, et al. Adv Exp Med Biol. 2020;1234:71-86. doi: 10.1007/978-3-030-37184-5_6. Adv Exp Med Biol. 2020. PMID: 32040856 Review.
NF-κB and STAT3 signaling pathways collaboratively link inflammation to cancer.
Fan Y, Mao R, Yang J. Fan Y, et al. Protein Cell. 2013 Mar;4(3):176-85. doi: 10.1007/s13238-013-2084-3. Epub 2013 Mar 13. Protein Cell. 2013. PMID: 23483479 Free PMC article. Review.
NF-kappaB and STAT3 are two major factors controlling the ability of pre-neoplastic and malignant cells to resist apoptosis-based tumor-surveillance and regulating tumor angiogenesis and invasiveness. Understanding the molecular mechanisms of NF-kappaB and STAT3 coo …
NF-kappaB and STAT3 are two major factors controlling the ability of pre-neoplastic and malignant cells to resist apoptosis-based tumor-surv …
The application and research progress of anti-angiogenesis therapy in tumor immunotherapy.
Tu J, Liang H, Li C, Huang Y, Wang Z, Chen X, Yuan X. Tu J, et al. Front Immunol. 2023 Jun 2;14:1198972. doi: 10.3389/fimmu.2023.1198972. eCollection 2023. Front Immunol. 2023. PMID: 37334350 Free PMC article. Review.
This review not only discusses the risk factors, mechanisms, and effects of abnormal and normalized tumor angiogenesis state on the immune environment, but summarizes the latest progress of immunotherapy combined with anti-angiogenic therapy. ...
This review not only discusses the risk factors, mechanisms, and effects of abnormal and normalized tumor angiogenesis state o …
Regorafenib for the Treatment of Sarcoma.
Blay JY, Duffaud F, George S, Maki RG, Penel N. Blay JY, et al. Curr Treat Options Oncol. 2022 Nov;23(11):1477-1502. doi: 10.1007/s11864-022-00990-0. Epub 2022 Sep 30. Curr Treat Options Oncol. 2022. PMID: 36178573 Review.
Tyrosine kinase inhibitors (TKIs), with a broad inhibition profile which have been shown to target tumor angiogenesis, have an established role in the treatment of sarcomas without characteristic driver alterations. ...
Tyrosine kinase inhibitors (TKIs), with a broad inhibition profile which have been shown to target tumor angiogenesis, have an …
Aspirin use and prostate tumor angiogenesis.
Fu BC, Wang K, Mucci LA, Clinton SK, Giovannucci EL. Fu BC, et al. Cancer Causes Control. 2022 Jan;33(1):149-151. doi: 10.1007/s10552-021-01501-6. Epub 2021 Oct 9. Cancer Causes Control. 2022. PMID: 34626297
METHODS: We examined associations between regular aspirin use and prostate tumor angiogenesis among 572 men from the Health Professionals Follow-up Study. ...
METHODS: We examined associations between regular aspirin use and prostate tumor angiogenesis among 572 men from the Health Pr …
Cannabinoids as Anticancer Drugs.
Ramer R, Hinz B. Ramer R, et al. Adv Pharmacol. 2017;80:397-436. doi: 10.1016/bs.apha.2017.04.002. Epub 2017 Jun 12. Adv Pharmacol. 2017. PMID: 28826542 Review.
Pharmacological effect and mechanism of orlistat in anti-tumor therapy: A review.
Hao X, Zhu X, Tian H, Lai G, Zhang W, Zhou H, Liu S. Hao X, et al. Medicine (Baltimore). 2023 Sep 8;102(36):e34671. doi: 10.1097/MD.0000000000034671. Medicine (Baltimore). 2023. PMID: 37682175 Free PMC article. Review.
It can induce tumor cells apoptosis or death, interfere with tumor cells' cycles controlling, suppress fatty acid synthase activity, increase ferroptosis, inhibit tumor angiogenesis, and improve tumor cells glycolytic. Thus, this review may shed new light on anti-tu …
It can induce tumor cells apoptosis or death, interfere with tumor cells' cycles controlling, suppress fatty acid synthase activity, increas …
Cancer-associated-platelet-inspired nanomedicines for cancer therapy.
Geranpayehvaghei M, Dabirmanesh B, Khaledi M, Atabakhshi-Kashi M, Gao C, Taleb M, Zhang Y, Khajeh K, Nie G. Geranpayehvaghei M, et al. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2021 Sep;13(5):e1702. doi: 10.1002/wnan.1702. Epub 2021 Feb 3. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2021. PMID: 33538125 Review.
Recently, increasing evidence has indicated that platelets are critically involved in the growth and metastasis of cancer cells by releasing a variety of cytokines and chemokines to stimulate cancer cell proliferation and various angiogenic regulators to accelerate tumor …
Recently, increasing evidence has indicated that platelets are critically involved in the growth and metastasis of cancer cells by releasing …
Tumor cells-derived exosomal noncoding RNAs in cancer angiogenesis: Molecular mechanisms and prospective.
Nazari-Khanamiri F, Abdyazdani N, Abbasi R, Ahmadi M, Rezaie J. Nazari-Khanamiri F, et al. Cell Biochem Funct. 2023 Dec;41(8):1008-1015. doi: 10.1002/cbf.3874. Epub 2023 Oct 16. Cell Biochem Funct. 2023. PMID: 37843018 Review.
In this review, we discuss the latest knowledge of the roles of exosomal noncoding RNAs in tumor angiogenesis Understanding the biology of exosomal noncoding RNAs can help scientists plan exosomes-based innovations for the treatment of cancer angiogenesis and cancer …
In this review, we discuss the latest knowledge of the roles of exosomal noncoding RNAs in tumor angiogenesis Understanding th …
Neurotransmitters as regulators of tumor angiogenesis and immunity: the role of catecholamines.
Sarkar C, Chakroborty D, Basu S. Sarkar C, et al. J Neuroimmune Pharmacol. 2013 Mar;8(1):7-14. doi: 10.1007/s11481-012-9395-7. Epub 2012 Aug 11. J Neuroimmune Pharmacol. 2013. PMID: 22886869 Free PMC article. Review.
Angiogenesis or formation of new blood vessels from existing ones and escape from immune surveillance are the two critical steps that ensure proper establishment and growth of the newly formed tumor. Thus understanding the novel pathways associated with tumor angiogenes …
Angiogenesis or formation of new blood vessels from existing ones and escape from immune surveillance are the two critical steps that ensure …
1,184 results